MT. LAUREL, New Jersey, June 25 /PRNewswire/ --

- New Release Assures More Accurate and Faster Processing, Enabling Confidence in a Project's Success

The latest release of TruePlanning by PRICE Systems (www.pricesystems.com) called TruePlanning 2008 was announced today. TruePlanning 2008 provides new upgrades to usability, significant enhancements to the Common Estimating Framework, and overall improvements to the Systems, Software, IT, Hardware and COCOMO estimation capabilities.

MONTREAL, June 25 /PRNewswire/ --

- New M-Series has more memory and cross-platform flexibility to drive multiple-monitor business applications with exceptional performance.

Matrox Graphics announces the availability of its M-Series multi-monitor graphics cards. These quad-capable display cards offer 512MB of memory, native PCIe x16 performance, and support for independent or stretched mode on up to four monitors simultaneously.

VAL DE REUIL, France, June 25 /PRNewswire/ --

- New 100 Million Euros Facility Incorporates Latest Technology to Produce Vaccines Meeting the Highest Quality Standards

VAL DE REUIL, France, June 25 /PRNewswire/ --

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today the inauguration of a high-tech vaccine production facility in France to respond to soaring demand worldwide. This new 100 million euros facility located in Val de Reuil (North West of France) incorporates the latest technology to produce vaccines that meet the highest standards of quality. It is part of 600 million euros investments undertaken by sanofi pasteur in France between 2005 and 2008.

NEW YORK, June 25 /PRNewswire/ --

- 11 million people in the UK visited social network sites in 2007

Facebook continues to trail MySpace in the US, but the online social networking site has overtaken its main rival in worldwide unique users. With almost 20 foreign-language versions of the site, starting with French, German and Spanish, Facebook has seen continuous growth throughout Europe. Now, with the new Chinese-language version, it is beginning its trajectory in Asia.

Luckily for palmophiliacs, there’s a new show in town, and it just may change the way we think about biometric security systems.

A new biometrics system called PalmSecure, developed by Tokyo-based Fujitsu Ltd., works by matching the unique vein pattern in your palm to an infrared scan of your palm stored in a database. The system is akin to fingerprinting, but improves upon the oft-used identification system of police stations everywhere.

LONDON, June 25 /PRNewswire/ --

Cascal N.V. (NYSE: HOO) ("the Company"), a leading provider of water services in seven countries, today announced that it has filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended March 31, 2008, with the U.S. Securities and Exchange Commission (the "SEC") in accordance with United States requirements. Cascal's Form 20-F can be accessed on the Investor Relations page of the Company's website at www.cascal.co.uk, as well as on the SEC's website at www.sec.gov. Interested parties may also request a complimentary paper copy of the filing by contacting Yemi Rose, at yrose@kcsa.com.

About Cascal N.V.

LONDON, June 25 /PRNewswire/ --

- Quark Pharmaceuticals to develop drug candidate for prevention and treatment of delayed graft function in kidney transplantation

Silence Therapeutics plc (London AIM: SLN) today announces that the U.S. Food and Drug Administration (FDA) has approved a Quark Pharmaceuticals Inc ("Quark") Investigational New Drug application (IND) for an siRNA therapeutic product based on Silence's unique proprietary chemistry. The product, DGFi, was discovered and is being developed by Quark for use in kidney transplantation. Rights to the AtuRNAi structure of DGFi were licensed to Quark by Silence Therapeutics.

Energy from the sun and carbon dioxide fuel photosynthesis in plants and algae, making life on earth possible. Carbon that is fixed by plants is converted to starch and sucrose, which are utilized by plants for energy and to build biomass.

Human evolution and society have been intimately tied to our exploitation of plant biomass for food, fuel, tools, and shelter. However, to be usable, the starch carbohydrate stored in plants must be broken down to component sugars. Some aspects of starch metabolism have been known for many years, but regulation of the process and exact physical mechanisms are still not well understood.

With new information emerging from genome sequencing and mutational analyses, we are beginning to gain a better understanding of these complex and finely tuned processes. Such knowledge is especially critical as we struggle with issues of energy and food supply.

ANN ARBOR, Michigan, June 25 /PRNewswire/ --

Terumo Heart, Inc. announced today approval from the Institutional Review Board (IRB) at the University of Michigan to move forward with the DuraHeart(TM) Left Ventricular Assist System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant (BTT) indication. Francis Pagani, M.D., Ph.D., Director of the Adult Heart Transplantation and Artificial Devices Program at the University of Michigan, will serve as the National Co-Principal Investigator of the U.S. Pivotal Trial.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO )